Renal function and drug-eluting stent

Carlo Briguori, Flavio Airoldi, Alaide Chieffo, Mauro Carlino, Matteo Montorfano, Antonio Colombo

Research output: Contribution to journalArticlepeer-review


We assessed the relationship of renal function and the clinical outcome in 2314 patients treated by drug-eluting stent (DES). At 24 months, the cumulative major adverse cardiac events (MACE) rate and the composite of death and myocardial infarction were higher in the patients with severe chronic kidney disease (CKD). Severe CKD identifies patients at high risk of MACE following DES implantation.

Original languageEnglish
Pages (from-to)92-94
Number of pages3
JournalInternational Journal of Cardiology
Issue number1
Publication statusPublished - Jun 25 2010


  • Chronic kidney disease
  • Drug eluting stent
  • Outcome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Renal function and drug-eluting stent'. Together they form a unique fingerprint.

Cite this